NSC 95580

Drug Profile

NSC 95580

Alternative Names: Hexabid; Hexamethylene bisacetamide

Latest Information Update: 19 Apr 2007

Price : $50

At a glance

  • Originator National Cancer Institute (USA)
  • Class Acetamides; Cytostatics; Small molecules
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Preleukaemia

Most Recent Events

  • 23 Mar 2000 A preclinical study has been added to the pharmacodynamics section
  • 03 Sep 1998 Profile reviewed
  • 30 Nov 1994 Hexamethylene bisacetamide is now called NSC 95580
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top